PATENT CLAIM ANALYSIS

Application Number: 16258606
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "374000"]

Abstract:
The present invention is directed to methods of treating and/or ameliorating portal hypertension by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.

Claim (Index 13):
The method of  claim 7 , wherein the mammal is a human patient and the therapeutically effective amount of ifetroban reduces portal hypertension in the patient compared to placebo as measured by a test selected from the group consisting of Hepatic Venous Pressure Gradient Measurement, platelet function assessment, e.g. by rotational thromboelastometry, thromboelastography, and evaluation of serum biomarkers for fibrosis and inflammation and combinations of any of the foregoing.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 99.0
- Lexical Diversity: 1.11538
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14715143', '15592727', '16240368', '15608507', '16004666']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8347767356792917
- 35 USC 102 Novelty (BERT): 0.5781577723952371
- Combined Prediction Score: 0.8091148393508862
- Mean Citation Score: 481.51012
- Max Citation Score: 512.1572
- Similarity Product: 370.6237068631649

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test